[Form 4] Preformed Line Products Co Insider Trading Activity

Rhea-AI Filing Summary

Morcos Assaad A, Vice President, US Manufacturing of Preformed Line Products Co (PLPC), executed a routine option exercise and sale on 08/04/2025. He exercised the final vested tranche of 625 stock options from a 2022 grant at an exercise price of $61.24 per share and subsequently disposed of 625 common shares at $154.28 per share, leaving 0 direct common shares following the transactions. The filing shows he continues to hold 681 restricted stock units and 7,500 outstanding stock options granted on 12/11/2024 with scheduled vesting through 2027. The form lists the specific vesting schedules for the 2022 and 2024 option grants and confirms the transaction was reported by power of attorney.

Insights

Securities Analyst

TL;DR: Routine option exercise and immediate sale; not a company-changing event.

The reporting person exercised 625 options at $61.24 and sold the resulting shares at $154.28. This is documented as the final vested tranche from a 2022 grant. The transaction appears procedural: exercise of vested options followed by a sale, leaving the filer with no direct common shares. Material outstanding equity holdings remain in the form of 681 RSUs and 7,500 options from a 2024 grant with multi-year vesting. For investors, this is a disclosure of insider liquidity rather than a change in control or strategic direction.

Corporate Governance Expert

TL;DR: Disclosure aligns with Rule 16 reporting; transaction details and vesting schedules are clearly stated.

The Form 4 specifies the grant dates, vesting tranches, exercise price, and sale price for the exercised tranche. The explanation clarifies vesting timelines for both the 2022 and 2024 grants and indicates the exercise related to the last vested tranche. The form is signed via power of attorney and reports ownership forms as direct. This is a standard insider reporting event with transparent terms and no governance red flags visible in the filing content.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Morcos Assaad A

(Last) (First) (Middle)

660 BETA DRIVE

(Street)

CLEVELAND OH 44143

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
PREFORMED LINE PRODUCTS CO [ PLPC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	VP, US Manufacturing

3. Date of Earliest Transaction (Month/Day/Year)
08/04/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares, $2 par value per share	08/04/2025		M		625(1)	A	$61.24	625	D
Common Shares, $2 par value per share	08/04/2025		D		625	D	$154.28	0	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee stock option (right to buy)	$0	08/04/2025		M			625(1)	(1)	(1)	Common Shares, $2 par value per share	625	$61.24	0	D
Restricted stock units	$0							(2)	(2)	Common shares, $2 par value	681		681	D
Employee stock option (right to buy)	$0							(3)	(3)	Common Shares, $2 par value per share	7,500		7,500	D

Explanation of Responses:

1. On July 19, 2022, the reporting person was granted 2,500 stock options, of which 1,250 vested on July 19, 2023, 625 vested on July 19, 2024, and the remaining 625 vested on July 19, 2025. This transaction refers to the exercise of the last vested tranche of 625 shares at the option strike price.

2. Restricted stock units vest 3 years from the date of grant.

3. On December 11, 2024, the reporting person was granted 7,500 stock options, of which 3,750 will vest on December 11, 2025, 1,875 will vest on December 11, 2026, and the remaining 1,875 will vest on December 11, 2027. The expiration date is 10 years from the grant date.

Remarks:

	/s/ Caroline S Vaccariello, by power of attorney	08/11/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did PLPC insider Morcos Assaad do on 08/04/2025?

He exercised 625 stock options at an exercise price of $61.24 and sold the resulting 625 shares at $154.28 on 08/04/2025.

How many common shares does Morcos Assaad own after the reported transactions?

0 direct common shares are reported as beneficially owned following the transactions.

What equity awards does the filing show Morcos Assaad still holds?

The filing shows 681 restricted stock units and 7,500 stock options from the 12/11/2024 grant, with vesting scheduled through 2027.

What was the exercise price and sale price for the exercised tranche?

The exercised tranche had an exercise price of $61.24 per share and was sold at $154.28 per share.

Which company and ticker is this Form 4 for?

The Form 4 reports insider activity for Preformed Line Products Co (PLPC).